ÂÜÀòÂÒÂ×

The Leadership Team at Collaborative Trajectory Analysis Project drives strategic direction and decision-making to advance Duchenne drug development. Comprising co-founders and seasoned executives, this team leverages their expertise to foster collaborations, align clinical goals, and ensure the successful execution of innovative solutions that address critical challenges in the field.